np event 2254995 0E193A 1
Nov 11, 2025
- Nov 10, 2026
AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors for the Management of Patients with Generalized Myasthenia Gravis
1.0

Already have an Account? Log In
Don’t have an account? Register Today

 Claim your Certificate

Related Courses

np document 888746 0E193A 5
Cardiology
PCSK9 Inhibitors in Primary Prevention: A New Paradigm for Family Physicians
np document 888746 0E193A 5
Neurology
The Evolving Role of High Efficacy, Anti-CD40 Therapeutics for Relapsing Multiple Sclerosi...
np document 888746 0E193A 5
Neurology
Review of Biosimilar Therapeutics for Patients with Relapsing Multiple Sclerosis